Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,813-13,824 of 23,847
Drug study icon
CompletedNCT04315792

Endoxifen for Bipolarity

This study is completed in the United States. It is testing endoxifen for Bipolarity.

In Miami
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Jina Pharmaceuticals Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT02704390

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Chiayi City
ADHDDrugFrom 6 Years to 18 Years
Countries
Taiwan
Sponsor
Orient Pharma Co., Ltd.
Condition
ADHD
Drug study icon
CompletedNCT00499863

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

Multiple locations, including Scottsdale
ADHDDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Noven Therapeutics
Condition
ADHD
Behavioral study icon
TerminatedNCT02512367

Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in people with Schizophrenia.

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

Multiple locations, including Besançon
SchizophreniaBehavioralOver 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire Dijon
Condition
Schizophrenia
Drug study icon
CompletedNCT00501293

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Scottsdale
ADHDDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Noven Therapeutics
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.